SY30 - NIDDK Early-Stage Investigator Symposium: Neural Control of Metabolic Organs

Symposium Chair(s)

• 

  Roger Cone, PhD

  Mary Sue Coleman Director, Life Sciences Institute
  University of Michigan
  Ann Arbor, MI, United States

  Disclosure(s): Courage Therapeutics: Advisory Board (), Board Member/Officer/Trustee (), Consultant (), Contracted Research (Principal Investigators must provide information, even if received by the institution) ()
• PS

  Patrick Sweeney, PhD

  Assistant Professor
  UNIVERSITY OF ILLINOIS
  Urbana, IL, United States

  Disclosure(s): No financial relationships to disclose

This NIDDK Early-stage Investigator Symposium showcases emerging leaders and rising stars who are focused on the neural control of metabolic organs that regulate body weight, temperature, and glucose homeostasis in animal models. The overarching concept of this symposium emphasizes the role of sensorimotor networks in the central nervous system in monitoring the internal milieu and enacting control of metabolic end-organs like the pancreas and brown and white adipose tissues.

Presentations:

• 1:45 PM - 2:07 PM CT

  Mechanisms for Hypothalamic Control of Glucose Mobilization
  

  Symposium Speaker: Alison Affinati, MD, PhD (she/her/hers) – University of Michigan
• 2:07 PM - 2:29 PM CT

  Defining the Neurocircuit Activated by the VMH to Control Energy Expenditure
  

  Symposium Speaker: Jonathan Flak, PhD – Indiana University School of Medicine
• 2:29 PM - 2:51 PM CT

  Deconstructing Brainstem Circuits for Visceral Senses
  

  Symposium Speaker: Chen Ran, Ph.D. – The Scripps Research Institute
• 2:51 PM - 3:13 PM CT

  Role of Hypothalamic IRF3 Transcriptional Dysregulation in Obesity
  

  Symposium Speaker: Frankie Darryn Heyward, Ph.D. (he/him/his) – UT SOUTHWESTERN MEDICAL CENTER